Primary Sclerosing Cholangitis clinical trials
20 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
- Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
- Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
- A Study of SIPLIZUMAB in AILD and LT Patients
- Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
- Detoxification of the Liver In PSC (Dolphin)
- A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
- Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
- A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
- Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
- Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
- Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
- Primary Sclerosing Cholangitis in Children
- MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
- A-LiNK: Improving Outcomes in Autoimmune Liver Disease
- Biobank for Cholestatic Liver Diseases.
- MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
- Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
- PET/MRI of Primary Sclerosing Cholangitis
- TruGraf Liver Gene Expression Serial Test
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Primary Sclerosing Cholangitis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.